Ceva Animal Health UK is now providing Logic Oral Hygiene Gel sample sachets to veterinary practices free of charge, to enable clients to try before they buy on their cat or dog

In addition, to help veterinary practices promote the importance of dental hygiene, new waiting room display materials are also available.

To obtain your free Logic sample sachets or waiting room display material, please telephone 01494 781510 or e-mail customerservicesuk@ceva.com.

Kruuse is to launch a new Manuka honey dressing at BEVA 2011 in September.

Kruuse says that honey has been used as a topical anti-microbial agent and dressing for over 2000 years, and that honey derived from the nectar of the Manuka tree (Leptospermum scoparium) has its own unique chemical properties. Manuka honey contains glucose oxidase imparted by the bees during its collection and storage. This enzyme facilitates low level release of hydrogen peroxide when in the presence of wound exudates and thus supports cellular proliferation and metabolism through an antioxidant effect. The high sugar and low pH content creates a high osmotic potential which gives honey excellent debridement and anti-inflammatory properties.

The company says that one of the biggest difficulties with the use of honey in wound dressings is ensuring that once applied it stays over the wound area. Many attempts to coat dressings have been unsuccessful; often the active honey ingredient is left within the packaging severely reducing the effectiveness of the dressing. Kruuse says its Manuka dressings have the active honey impregnated 'within' the dressing, which ensures precise and easy application even if wearing surgical gloves.

The Kruuse Manuka dressings range comes in impregnated adherent (Kruuse Manuka AD), non-adherent dressing (Kruuse Manuka ND) and 15g tube of Manuka G.  Each dressing comes in 3 sizes 5x5 cm , 10x12.5 cm and the KRUUSE Manuka roll (10x100 cm) a unique product ideal for large vertical wounds. E.G. Equine forelimb.

Kruuse also says that the antimicrobial potency in Manuka honey is rated by a standardised rating known as Unique Manuka Factor (UMF). The higher the UMF the better the antimicrobial effect.  A minimum UMF of 10 is required to ensure sufficient effect in the wound environment, Kruuse Manuka Honey Wound Dressings have a Unique Manuka Factor of 15.

There is a restricted annual supply of Manuka honey as this unique product supply is controlled by a small number of producers in New Zealand. Many current honey products available use blends of Manuka honey with other poorer quality honey, these are often less effective. Kruuse Manuka uses 100% Manuka honey in all its dressings with the profits of the sale being returned directly to the Maori tribe that oversee the production of Manuka honey.

Andrew Groom, Managing Director Kruuse UK Ltd. said: "I am very excited that we have been able to secure a direct connection to supply this unique product with the knowledge that the Maori suppliers will see the returns for generations to come whilst this new range of dressing will add huge versatility for day to day wound management!"

Hill's Pet Nutrition has announced that it is developing a new webinar series for veterinary nurses.

The three webinars will all be free of charge. Although the topic of the webinars remains a closely guarded secret for now, Hill's says it is promising a sparkling line up of speakers who will help nurses to develop a different mindset about a significant number of their patients, with far reaching consequences for their clinical approach. There will also be tools, models and frameworks provided that can then be used in practice to evolve some of the services most practice offer.

There will be a CPD certificate to download after the event and the webinars will also qualify for CVE points for nurses from Ireland.

Tim Dobbins, Associate Veterinary Affairs Manager said: "The fantastic and enthusiastic response to our feline webinar series has convinced us that this technology meets the needs of veterinary professionals perfectly. The savings in time and energy are very much valued by busy professionals with work and family commitments. We have a long heritage of providing CPD for nurses through our VNA programme and we are keen to continue to support their ongoing professional development by building on those skills in relevant areas."

To be sure of grabbing a place, veterinary nurses, trainees and ANAs can send Hill's a note of interest in attending the webinars by calling 01923 814454 or emailing Jane Quail (Jane_Quail@hillspet.com). They will then be sent priority notification and full details of the webinars, as soon as the booking facility is open.

Petplan has launched this year's Insurance Advisor Award in association with VetNurse.co.uk, and is calling for nominations.

The award is to recognise the hard work and dedication that Petplan Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.

Petplan says pet owners often look to vet staff to help them better understand veterinary procedures, treatment and medication, but they're also increasingly looking for advice about insurance, and that is why it is important that a formally trained member of staff is available to answer customer queries when it comes to pet insurance.

Petplan works with over 4,000 veterinary practices throughout the UK to promote pet insurance. These are Appointed Representative (AR) practices who receive training and certification to speak about specific insurance policies. The PIA scheme is an extension of this - AR practice staff can train to become a dedicated Pet Insurance Advisor by registering on www.petplan.co.uk/pia

Becoming a PIA allows vet staff to earn valuable CPD points whilst developing transferable skills such as confidently promoting products and handling client objections.

Deputy Veterinary Practice Manager Kelli Vogt, of Polsloe Veterinary Clinic in Exeter, who won the 'Petplan Insurance Advisor Award 2010', said: "The scheme is such a great programme and I recommend it to all my colleagues and anyone that will listen. It's a great link between veterinary practices and insurers and it means that we can really help pet owners have financial security should anything happen. The more pet owners are informed of the importance of pet insurance the more likely it'll become mandatory, which will allow them to always get the best possible treatment for their pet without having to worry about the financial implications."

Director of Petplan, Neil Brettell said: "We are incredibly proud to help recognise the hard work and dedication that Petplan Insurance Advisors give their customers, helping to keep them constantly informed and up-to-date. So please get your nominations in!"

To nominate your dedicated colleague for the Petplan Insurance Advisor Award, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a 16GB Ipad2 with WiFi, worth £399.

Nominations close on 9^th September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress, taking place from Friday 7th - Sunday 9th October 2011.

For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.

To find out more about Petplan visit http://www.petplan.co.uk/

Alstoe Animal Health has launched Easeflex for Cats, a mobility support supplement containing Glucosamine, Chondroitin, MSM and anti-oxidants in a palatable triangular-shaped chew.

Alstoe says stiffness in cats may be linked to changes within the synovial joints and can often go unrecognised. To help owners identify the problem, Alstoe has invented "Chedda" the Easeflex cartoon cat. The client information pack that Alstoe offers to practices consists of leaflets with graphics which outline to the owner how stiffness affects Chedda's lifestyle. .

Sales of joint supplements for cats have lagged well behind those for dogs. Alstoe says this can be explained by the difficulty in administration to chronically affected cats, but that Easeflex's unique texture, shape and flavoured base of fish and cheese, should lead to a marked improvement in compliance rates amongst pets and owners.

Easeflex for Cats is now available at wholesalers and the client information material featuring "The adventures of Chedda" is available from Alstoe by calling 01347 878606 or contacting info@alstoe.co.uk.

Virbac Animal Health has produced a Pet Oral Hygiene System point of sale kit for practice reception areas.

The pack includes information for owners on periodontal disease and gingivitis and advice on preventative routine care. It also provides guidance for owners who struggle to brush their pet's teeth correctly, including where to find Virbac CET 'You Tube' footage.

Virbac Oral Care product manager Chris Geddes MRCVS says still more is needed when it comes to oral home care: "Some experts state that four out of every five dogs over the age of three suffers from periodontal disease - despite this many pet owners have no form of oral care programme.

"The idea behind this kit is to highlight to owners the importance of oral hygiene at the time when they are in the most appropriate place to get expert advice!"

Packs are free to any practice spending £50.00 or more on the Virbac oral care range including VeggieDent chews and Vet aquadent drinking solution.

For more information contact your local Virbac territory manager or call Virbac on 01359 243243.

The Royal College of Veterinary Surgeons is seeking feedback on a new draft Code of Professional Conduct for Veterinary Nurses.

The new draft Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Nurses, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.

It is the benchmark for professional conduct against which registered veterinary nurses will be measured in any hearings on serious professional misconduct held by the recently-introduced VN Disciplinary Committee.

The purpose of the review is to ensure that guidance to the profession, and the public, is clear, for example, using consistent language to distinguish between what must be done and what is advised.

The new Code is a short, principles-based document, using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance.

The consultation follows an earlier one for a new draft Code for veterinary surgeons that closed at the end of June: the new Code for veterinary nurses follows the format and style of that for veterinary surgeons. Comments made during the veterinary surgeon consultation will be taken account of alongside comments made during this new consultation.

For the first time, the draft proposes that veterinary nurses make a declaration on joining the VN Register, which underlines the primary importance of animal health and welfare: "I PROMISE AND SOLEMNLY DECLARE that my constant endeavour will be to ensure the welfare of animals committed to my care and that I will pursue the work of my profession with integrity and accept my responsibilities to my clients, the public, the profession and the Royal College of Veterinary Surgeons."

Comments on the proposed draft are invited from the veterinary nursing profession, the veterinary profession and the public, particularly on the issue of whether the Codes for veterinary nurses and veterinary surgeons ought to be combined.

Andrea Jeffery, the RCVS Veterinary Nurses Council member who led the group tasked with developing the new Code, said: "It is 50 years since the start of the veterinary nursing profession and the changes proposed in the Code reflect the development of our professional role over this time.

"This new Code is a simplified document that focuses on key principles and which will be supported by more detailed guidance. Although it follows the format of the draft Code for veterinary surgeons, it is important that we recognise our unique position as veterinary nurses."

The new Code, together with the consultation paper, can be downloaded at www.rcvs.org.uk/VNcodeconsultation.

Comments should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 21 October 2011.

Vétoquinol has released the results of a survey of 1000 dog owners, which looked into their attitudes towards long-term medication for their pet¹.

Owners were asked to rate how important various factors were to them when it came to giving medicine long term to their dog. They were also asked to consider what they felt was most important to their vet when it came to choosing a medicine.

• Effectiveness: 85% of dog owners felt that effectiveness was highly important.
• Side effects: 77% of dog owners said a limited range of side effects was either highly important (47%) or important (30%) in deciding their preference for a particular medication for their dog. Interestingly, owners thought that veterinary surgeons are slightly less concerned about side effects than they are: only 34% of owners think side effects are highly important to their vet). 
• Easy of administration: Only 24% of owners rated how easily a medication can be given as highly important. 28% said it was of medium importance.
• Established brand: 30% of dog owners felt this was of medium importance, and 24% felt this of least importance.
• Cost: surprisingly, the cost of medication was found to be one of the least important factors, with only 14% saying it was highly important to them.

Vétoquinol says the fact that dog owners rate the effectiveness of a medication much more highly than the cost means there is very little reason to compromise on treatment based on a presumption of what clients will want to pay. These findings are also largely very positive in that they suggest that dog owners believe that in many areas vets are making decisions based on criteria that are important to owners. The area where there is the greatest mismatch is over the risk of side effects of medication.

Pet owners think that vets may take the risk of side effects from long-term medications less seriously than the owners themselves might prefer. It suggests that the risk of potential harm, no matter how small the risk of actual harm is, may be more unacceptable to the dog owner than vets and nurses might otherwise presume. When prescribing long-term medication there is a need to talk about the risks associated with medication more openly and to take the client's attitudes to risk into consideration.

^1. A survey of 1048 dog owners, carried out by petbuzz, on behalf of Vétoquinol, March 2011

The Animal Health Trust has cut the first sod of a new cancer centre for animals in Suffolk.

The AHT's Cancer Centre will provide all three treatment options: surgery, chemotherapy and radiotherapy, on one site. The cancer facility is being purpose-built to treat horses, dogs and cats.

Sue Murphy, Head of Clinical Cancer Treatment at the AHT, said: "Having all three treatment options on one site means that whatever the diagnosis, we will be able to offer each and every patient the very best options for their specific case. With one in four dogs and one in six cats developing cancer at some time in their life this new centre will help many more animals - from Suffolk, East Anglia and all across the UK."

The new centre will also further research into cancer. Treating animals with all types of the disease will enable the AHT's vets and scientists to expand current knowledge about cancer. This will help with the development of new ways to diagnose and treat the disease.

Vets and scientists at the AHT already work collaboratively with cancer researchers looking at the disease in humans. There are a number of links between human and animal cancers which have already been identified. It is hoped that knowledge gained from the AHT Cancer Centre may also help in the understanding of cancer in people.

The AHT hopes the building will open in summer 2012 . It is launching an appeal to raise much needed funds to equip the centre with a linear accelerator. This piece of specialist equipment works by delivering high-energy radiation beams to break cancerous tumours down while sparing the surrounding normal tissue.

The AHT Cancer Centre will be one of only six veterinary facilities in the UK to house a linear accelerator.

Sue Murphy added: "Currently, there is no way to tell which animals will, and which animals won't, develop cancer. It could happen to any animal at any time. This new centre will give more animals a fighting chance of beating the disease, enabling them to lead long and healthy lives. The fact that treatments developed to benefit our pets may also lead to improvements in the prevention and treatment of cancer in humans makes this centre all the more important.

"I would urge you to donate whatever you can to help equip the centre. Your donation, however large or small, will help many more animals beat cancer and it may also help in the fight against cancer in people."

If you would like to make a donation to the AHT Cancer Centre please visit www.aht.org.uk or telephone 01638 555648.

Alternatively you can make a £5 donation by textingVETS24 £5 to 70070

The British Veterinary Association and its specialist cattle division the British Cattle Veterinary Association have welcomed today's announcement by Defra that it is strongly minded to include a controlled cull of badgers as a key component of the bovine tuberculosis (TB) eradication plans for England.

The two associations have long supported the need to control TB in both cattle and wildlife, including the need for a targeted, humane cull of badgers in specific parts of the country.

Following a consultation exercise which closed in December 2010, Defra has today announced: 

• A 9-week consultation on plans to license groups of farmers and landowners to carry out controlled culls of badgers in specific areas
• Ongoing cattle measures and planned measures, including reducing compensation where TB tests are overdue and removing some exemptions to pre-movement testing
• £20 million investment over the next five years to develop effective cattle and oral badger vaccines

The BVA and BCVA jointly responded to Defra's 2010 consultation to say that the available science supported the case for a badger cull, alongside the need for stricter cattle control measures, in those areas where badgers are regarded as a significant contributor to the persistent presence of TB. The response also emphasised strongly that any cull of badgers had to be done in a humane and effective manner.

The BVA and BCVA say that today's announcement shows Defra has listened closely to their concerns. Through the consultation response the BVA and BCVA raised the issue of the efficacy of an industry-led cull using controlled shooting (as opposed to cage trapping and shooting) and stated firmly that any cull must be monitored for humaneness. Both of these issues have been considered in depth by Defra and appear to have been addressed in the plans.

The associations say they will be looking closely at the detail of the guidance issued today and will be responding to the consultation.

Harvey Locke, President of the BVA, said: "The BVA and BCVA have long argued for a targeted, humane badger cull to be used alongside stricter cattle controls. We believe that failure to tackle wildlife sources of TB infection has prolonged the presence and enhanced the spread of infection in all affected species populations.

"We recognise that this is a very emotive and difficult decision but we believe that the science supports this policy and we support Defra's commitment to tackling this devastating disease.

"We are particularly pleased that this announcement has not been delayed until after the summer recess, which demonstrates the seriousness of the need to tackle TB."

John Fishwick, President of BCVA, added: "We welcome today's announcement which indicates that a humane and carefully targeted cull of badgers can contribute to the control of this dreadful disease.

"We are particularly pleased that the veterinary profession's concerns that any cull must be humane and well monitored appear to have been listened to and we will now study the proposals in detail.

"An industry-led cull will be an enormous undertaking for everyone involved and it is vital that we get the detail right from the outset; for the sake of cattle, wildlife and industry."

Meanwhile, the RSPCA has expressed its devastation at the announcement.

According to the charity, new research has been published which shows that badger culling can more than double the risk of TB infecting cattle¹. High-profile voices such as Sir David Attenborough and government adviser Lord John Krebs have also weighed in, saying a cull could "make the situation worse" and be "ineffective".

David Bowles, Director of Communications for the RSPCA, said: "Today is a black day for badgers - a day we have been dreading.

"At a time when the Welsh government has stepped back from a cull, the government in England is slowly shredding its own animal welfare credentials."

The RSPCA says it agrees that action is needed to combat bovine TB in cattle, but does not think action is synonymous with culling. The charity believes that vaccination of badgers, increased levels of testing, improved biosecurity and stricter controls on the movement of cattle are more effective ways of dealing with the problem in the long-term and eradicating bovine TB in cattle for good.

Colin Booty, senior scientist for the RSPCA, said:  "The RSPCA is sympathetic to farmers struggling to cope with the effects of this crippling disease and thinks that the problem of bovine TB in cattle needs a sustainable and effective solution.

"But this is not such a solution. We believe that the government have taken the wrong fork in the road with this risky policy.

"This cull will contribute little or nothing to the long-term goal of eradicating TB nationally. Instead it will wipe out huge numbers of this much-loved species, including many animals which are healthy."

¹ The New Medical Research Council study came from Imperial College London and were published in the Royal Society Journal Biology Letters. They were based on analysis of data from the 10-year Randomised Badger Culling Trial set up by the Department for Environment, Food and Rural Affairs (Defra) in 1998.

The RCVS Charitable Trust has teamed up with the Foundation for Social Improvement (FSI) for the launch of the Great Big Small Charity Car Draw 2011.

The draw enables small charities, such as the RCVS Charitable Trust, to sell tickets to supporters which offer a chance of winning a brand new Fiat 500 1.2 Pop. Each ticket costs only £2, and the Trust will receive £1.90 for every ticket it sells.

Tickets can be bought securely online at http://trust.rcvs.org.uk/support-us/get-involved/win-a-fiat-500/ or directly from the Trust office on 020 7202 0721 or by emailing fundraising@rcvstrust.org.uk.  Books of tickets are also available to sell to colleagues, friends and family. The deadline for buying tickets is September 16th 2011 with the draw taking place on 25th October 2011.

Here are a few examples of what reviewers have been saying about the Fiat 500:

"The Fiat 500 is both stylish and fun. The modest running costs complement the engaging handling. So, this nimble little city car can be enthusiastically thrown into corners and it should emerge grinning like a Cheshire Cat." Motoring.co.uk

"I love my Fiat 500 1.2 Pop from the moment I drove off in it. Great fun to drive on the motorway and in town for parking into slots others cannot!" What Car?

"It's absolutely fantastic. It drives like a dream. Everybody admires it." Fiat Forum

For further information on the car draw, please contact Fiona O'Regan on 020 7202 0743 or Rebecca Fellows on 020 7202 0721.  Alternatively email fundraising@rcvstrust.org.uk.

The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).

In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.

However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.

The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.

The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.

Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.

"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.

"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.

"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."

Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.

"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."

Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.

The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.²

According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.^3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence.  Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.⁵ This quality of evidence is, says Hill's, in contrast to many supplements.

John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."

Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis¹, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.

Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive  two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.

Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk  or http://www.hillspetmobility.ie/

References

1. Hill's data on file
2. Zyman group, Hill's funded brand equity research - mobility - Jan 2009
3. Fritsch D, Allen T A , Dodd C E, et al. Dose-titration effects of fish oil omega-3 fatty acids in osteoarthritic dogs. J Vet Intern Med 2010; 24:1020-1026.
4. Sparkes A, Allen T A, Fritsch D, and Hahn K A. Effective dietary management of spontaneous appendicular osteoarthritis in cats. Unpublished.
5. Fritsch D, Allen TA, Dodd C E, et al. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega 3-fatty acids on the Carprofen dosage in dogs with osteoarthritis. J. Amer. Vet. Med. Assoc.Vol 236, No. 5, March 1, 2010; 535-539.
6. Caterson B,Little C B, Cramp J et al. Eicosapentaeonate supplementation abrogates canine articular cartilage degradation in 'in vitro' explant culture systems, in Proceedings, Hill's European Symposium on Osteoarthritis and Joint Health 2005; 14-19.
7. Innes J, Gabriel N, Vaughan-Thomas A. Feline Arthritis: Changes in Articular Cartilage, Development of a Degradation Model, and Testing of Candidate Nutrients. In: Proceedings of Hill's Global Mobility Symposium Sunny Isles Beach,Florida, USA April23-25,2008:pp.24-28.
8. Frantz N. Effect of Prescription Diet j/d^TM Canine on clinical measures, cartilage biomarkers, and metaboloic changes in dogs with osteoarthritis. J. Vet. Int. Med. 2010; 24: 718 Abstract 156.
9. Hill's Data on File.